Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-41
Closed -$10K 221
2021
Q2
$10K Hold
41
﹤0.01% 310
2021
Q1
$10K Hold
41
﹤0.01% 319
2020
Q4
$9K Hold
41
﹤0.01% 338
2020
Q3
$10K Sell
41
-39
-49% -$9.66K ﹤0.01% 355
2020
Q2
$19K Sell
80
-155,292
-100% -$35.4M ﹤0.01% 337
2020
Q1
$31.5M Sell
155,372
-6,301
-4% -$1.38M 0.55% 54
2019
Q4
$39M Sell
161,673
-3,127
-2% -$689K 0.48% 86
2019
Q3
$31.9M Buy
164,800
+206
+0.1% +$39.5K 0.43% 86
2019
Q2
$30.3M Sell
164,594
-5,747
-3% -$1.03M 0.4% 91
2019
Q1
$32.4M Buy
+170,341
New +$32.5M 0.41% 90

Other funds holding AMGN

Hexavest's AMGN Position: Q3 2021 in Review

Hexavest sold out of Amgen (AMGN) in Q3 2021, closing a stake of 41 shares — an estimated $10K sold.

Hexavest first reported a position in AMGN in Q1 2019 and held it in 10 quarters. The position peaked at $39M in Q4 2019. 2,133 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Hexavest reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • Hexavest sold 41 Amgen shares in Q3 2021, an estimated $10K.
  • Hexavest first reported a position in Amgen in Q1 2019 and held it in 10 quarters.
  • Hexavest's Amgen position peaked at $39M in Q4 2019.
  • 2,133 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.